New Clarivate Report Identifies Trends in Gene Therapy Poised to Impact Patients, Payers, Regulators and Developers

Report explores how developers are addressing challenges to market approvals and payment LONDON, May 2, 2023 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced the release of…